BenzingaOctober 23, 2026 at 6:17 AM NY4 Days Ago
Wells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $120
Wells Fargo analyst Larry Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $119 to $120.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
